Autolus sets AGM for June 26; two directors to step down; new equity plan proposed

Autolus Therapeutics plc

AGM on June 26, 2025; resolutions include adoption of 2024 accounts, auditor reappointment (EY LLP), and director re-elections.
Directors Joseph Anderson and Martin Murphy will not stand for re-election, ending their terms after the AGM.
New Employee Share Purchase Plan with Sharesave Sub-Plan (up to 3M shares) approved by Board on May 20, 2025, subject to shareholder approval.
Remuneration report and policy, plus re-election of Dr. Robert Iannone and Dr. Ravi Rao, also on the agenda.

item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.